Status:
COMPLETED
Preoxygenation Using THRIVE Versus Facemask in Parturients
Lead Sponsor:
University of British Columbia
Conditions:
Preoxygenation
Eligibility:
FEMALE
19+ years
Phase:
NA
Brief Summary
This study aims to determine the duration for pre-oxygenation using THRIVE and facemask for parturients.
Detailed Description
We aim to determine the duration required for THRIVE and facemask preoxygenation in parturients for them to achieve ETO2 \>90%.
Eligibility Criteria
Inclusion
- Pregnant patients ≥36 weeks gestation.
- Non-laboring patients admitted for elective Cesarean delivery under neuraxial anesthesia or induction of labor.
- American Society of Anesthesiologists (ASA) class 2.
Exclusion
- Any medical conditions that are likely to affect gas exchange.
- Obstructed nasal passage.
- Unable to tolerate a tight fitting facemask.
- Body Mass Index ≥40 kg/m2.
- Patients who are in active labor (i.e. cervical dilation ≥4cm).
- Patients who are unable to give informed consent.
Key Trial Info
Start Date :
December 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 24 2020
Estimated Enrollment :
91 Patients enrolled
Trial Details
Trial ID
NCT03772574
Start Date
December 1 2018
End Date
April 24 2020
Last Update
May 24 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
BC Women's Hospital
Vancouver, British Columbia, Canada, V6H 3N1